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Laser-induced vapour nanobubbles improve drug
diffusion and efﬁciency in bacterial bioﬁlms
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Hindered penetration of antibiotics through bioﬁlms is one of the reasons for the alarming
increase in bacterial tolerance to antibiotics. Here, we investigate the potential of laser-
induced vapour nanobubbles (VNBs) formed around plasmonic nanoparticles to locally dis-
turb bioﬁlm integrity and improve antibiotics diffusion. Our results show that bioﬁlms of both
Gram-negative (Burkholderia multivorans, Pseudomonas aeruginosa) and Gram-positive (Sta-
phylococcus aureus) bacteria can be loaded with cationic 70-nm gold nanoparticles and that
subsequent laser illumination results in VNB formation inside the bioﬁlms. In all types of
bioﬁlms tested, VNB formation leads to substantial local bioﬁlm disruption, increasing
tobramycin efﬁcacy up to 1-3 orders of magnitude depending on the organism and treatment
conditions. Altogether, our results support the potential of laser-induced VNBs as a new
approach to disrupt bioﬁlms of a broad range of organisms, resulting in improved antibiotic
diffusion and more effective bioﬁlm eradication.
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The increasing antibiotic resistance against routinely usedantimicrobial agents threatens modern medicine world-wide and has reached alarming levels1. One of the reasons
for the decreased sensitivity of bacteria towards antibiotics is their
capability to form so-called bioﬁlms2–4. The increased tolerance
of sessile cells is multifactorial and includes avoidance of
antibiotic-induced oxidative stress, increased expression of anti-
biotic efﬂux pumps, and a reduced penetration rate of anti-
biotics5–7. The latter is sometimes referred to as the bioﬁlm
diffusion barrier and has two primary causes. First of all the
antibiotic can undergo physicochemical interactions with bioﬁlm
constituents, such as polysaccharides, extracellular DNA, or
enzymes, causing a decrease in the effective available concentra-
tion, and a slower penetration rate8,9. The second contribution to
the diffusion barrier is of a more physical nature and is a con-
sequence of the fact that sessile cells are packed together inside
this bioﬁlm in dense microcolonies of tens to hundreds of
micrometers in size10–12. Even though antibiotics may be small
enough to diffuse between the cells, the net ﬂux towards the
deeper cell layers is reduced compared to what is observed in
planktonic cultures. It is, therefore, of interest to develop strate-
gies to interfere with the dense bioﬁlm architecture so as to
improve the antibiotics ﬂux towards deeper cell layers13.
A traditional way to interfere with bioﬁlm integrity is by tar-
geting essential components of the bioﬁlm matrix14. Examples
include dispersin B that was used to degrade poly-N-acet-
ylglucosamine (PNAG) in staphylococcal bioﬁlm matrices15,16
and DNase I to cleave eDNA of Pseudomonas aeruginosa and
Staphylococcus aureus bioﬁlms17,18. Another approach is to
interfere with the bacterial communication system, called quorum
sensing (QS). Many studies reported that QS inhibitors affect the
bioﬁlm’s structural organization, thereby potentiating antibiotic’s
efﬁciency19–21. However, a downside of such pharmacological
approaches is their high speciﬁcity, i.e., the same treatment can-
not be used for a wide range of organisms. This becomes espe-
cially problematic in multispecies bioﬁlms in vivo, where one
must ﬁrst elucidate which bacteria and strains are involved in
order to select the most appropriate treatment22. A second dif-
ﬁculty arises from the fact that many targets for dispersal, such as
proteins, are not only present in bacteria but as well in humans,
leading to unwanted side effects, such as proteolytic degradation
of host-associated proteins23. Therefore, it is attractive to think of
physical methods to disturb bioﬁlm integrity as they may be more
widely applicable, being independent of the bioﬁlm composition.
One example is extracorporal shock waves generated by a shock
wave generator which were shown to disrupt P. aeruginosa and S.
aureus bioﬁlms, thereby increasing their susceptibility towards
ciproﬂoxacin24. Another example is ultrasound therapy, which
has been shown to increase gentamicin transport through P.
aeruginosa bioﬁlms25. However, the clinical applicability of
unfocused shock waves and ultrasound remains uncertain, as
detrimental tissue damage and bleeding can occur24,26,27.
Therefore, it is of interest to look for more reﬁned physical bio-
ﬁlm disturbance methods with the potential to be applied locally
with high spatial control.
Here, we present such a new concept making use of nano-
technology and laser treatment to locally disturb the bioﬁlm
integrity, potentiating antibiotics penetration and substantially
increasing their effectiveness. The concept is based on laser-
induced vapour nanobubbles (VNB) which can subtly but sig-
niﬁcantly expand the space between sessile cells. As depicted in
Fig. 1, bioﬁlms are ﬁrst treated with a suspension of gold nano-
particles (AuNP) which can gradually penetrate in between sessile
cells. When the energy of a high-intensity, short (<10 ns) laser
pulse is absorbed by such an AuNP, its temperature can rise to
several hundreds of degree, causing the water surrounding the
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Fig. 1 Schematic overview of the experimental protocol. a Formation of a 24-h bacterial bioﬁlm in vitro on a glass surface. b Penetration of AuNP through
the bioﬁlm. c After absorption of an intense nanosecond laser pulse, vapour nanobubbles emerge around the AuNP. d The mechanical force of VNB creates
more space between the cells allowing better penetration of antimicrobial agents
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particle to quickly evaporate, thus creating a quickly expanding
and subsequently imploding water vapour nanobubble28,29. The
localized shockwaves induced by VNB increase the space between
cells, allowing antibiotics to more easily reach the target cells,
even deep within the dense cell clusters. A particularly interesting
feature of laser-induced VNB is that the heat within the AuNP is
efﬁciently converted into mechanical energy30. This means that
net transfer of heat into the surrounding healthy tissue is avoided,
which is a known problem for the more traditional photothermal
therapies31. In addition, due to the ﬁne control of laser light and
localized action of VNB, the bioﬁlm disturbance effect can be very
precisely controlled in space.
We demonstrate the concept with Gram-negative (Bur-
kholderia multivorans, P. aeruginosa) and Gram-positive (S.
aureus) bioﬁlms, showing that cationic AuNP can penetrate deep
into these bioﬁlms and that laser-induced VNB can substantially
disturb their structural integrity. We show that the effectivity of
tobramycin added after such a treatment can be increased up to
more than 3 orders of magnitude depending on the organism and
treatment conditions. In addition, we show in an in vivo Cae-
norhabditis elegans model that there is negligible toxicity of the
AuNP at the concentrations used here. Together our ﬁndings
point to the potential of laser-induced VNB as a new approach to
disrupt bioﬁlms of a broad range of organisms, resulting in
improved antibiotic diffusion and more effective bioﬁlm
eradication.
Results
AuNP penetration through bioﬁlms. The concept of VNB-
mediated bioﬁlm disturbance for enhanced penetration of anti-
biotics was tested on two Gram-negative (B. multivorans and P.
aeruginosa) organisms and one Gram-positive (S. aureus). By
confocal laser scanning microscopy (CLSM) it was conﬁrmed that
they formed mature bioﬁlms after 24 h with dense bacterial
clusters (Supplementary Figure 1). For the generation of laser-
induced VNB, we selected cationic AuNP of 70 nm nominal size
suitable for VNB generation29,30. Dynamic Light Scattering (DLS)
size data, zeta potential, TEM image, and UV–VIS spectrum are
displayed in Fig. 2. AuNP were added to the mature bioﬁlms at a
ﬁnal concentration of 1.4E+ 10 AuNPmL−1 and incubated for
15 min. 3-D confocal images conﬁrmed that these AuNP were
indeed able to penetrate into the bacterial cell clusters (Fig. 3 and
Supplementary Movies 1,2,3).
Formation and visualization of VNB inside bioﬁlms. The next
step was to conﬁrm that VNB can be formed in bioﬁlms and
investigate their effect on bioﬁlm structure. The optical set-up to
generate and detect VNB is schematically shown in Supplemen-
tary Figure 2. Bioﬁlms were incubated with AuNP as described
above and selected cell clusters were irradiated with a single laser
pulse (7 ns, 561 nm) at a laser ﬂuence of 1.69 J cm−2. This is
above the VNB ﬂuence threshold32 of AuNP in water (Supple-
mentary Figure 3) to make sure that VNBs are effectively formed.
An EMCCD camera was synchronized with the pulsed laser by an
electronic signal generator, so that dark ﬁeld pictures could be
taken before, during, and immediately after irradiation.
Dark-ﬁeld images demonstrated successful VNB formation in
all three bioﬁlms incubated with AuNP, as can be seen in Fig. 4
(top 3 rows) where a number of VNB are indicated with red
arrows. VNBs are visible as brief (<1 µs typically) localized ﬂashes
of light within the laser-irradiated area as they scatter light from
the dark ﬁeld microscope. Most importantly, during VNB
formation cell clusters became clearly deformed by the mechan-
ical force exerted by the VNB shock waves. The images after laser
irradiation show that the deformation is to a large extent
permanent, indicating that the applied force is of sufﬁcient
AuNP characterization
c d
a b16
In
te
ns
ity
 (%
)
14
12
10
8
6
4
2
0
To
ta
l c
ou
nt
s
40,000
60,000
80,000
100,000
20,000
0
0 100 200 300 400 500
Hydrodynamic diameter (nm)
600 700 800 900 1000
Zetapotential (mV)
549 nm
100500–50–100
0.0
0.2
0.4
0.6
0.8
1.0
Ex
tin
ct
io
n
Wavelength (nm)
300 400 500 600 700 800
Fig. 2 AuNP characterization. a, b Size distribution (a) and zeta potential (b) of AuNP, as determined by DLS. cMorphological spherical structure of AuNP,
visualized by TEM. Scale bar= 500 nm. d UV–VIS spectrum of AuNP revealing a localized plasmon resonance peak at 549 nm
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magnitude to overcome the bioﬁlm’s elastic forces. In control
bioﬁlms without AuNP, VNB could not be formed upon laser
irradiation and consequently the bioﬁlm structure remained
unaltered (Fig. 4, bottom row). This clearly demonstrates that it is
the combination of AuNP and pulsed laser irradiation that leads
to the structural changes in the bioﬁlms.
Combining VNB-induced cluster disruption and antibiotics.
Having established that laser-induced VNB can cause substantial
deformation of dense cell clusters, we evaluated whether this leads
to increased antibiotic-mediated killing of sessile cells. We chose
to use tobramycin in concentrations of 32, 16, and 1024 µg mL−1
to treat B. multivorans, P. aeruginosa, and S. aureus bioﬁlms,
respectively. Note that these are suboptimal concentrations (i.e.,
they do not result in complete killing of the bioﬁlm, Fig. 5) so that
the additional effect of VNB on bioﬁlm killing could be quantiﬁed
to demonstrate our proof-of-concept. In this case, the bioﬁlms
grown in 96-well plates were scanned through the photoporation
laser beam so that each location of the sample received 1 laser
pulse. Treatment of a single well took ~3min, which was essen-
tially limited by the 20 Hz laser pulse repetition rate. After laser
treatment, tobramycin was immediately added to the bioﬁlms and
these were incubated further for 24 h, after which cell survival was
quantiﬁed by plate counting.
In B. multivorans bioﬁlms, pretreatment with VNB signiﬁ-
cantly increased the effect of tobramycin by approx. 80 times
(Fig. 5a). A similar effect was observed in P. aeruginosa and S.
aureus bioﬁlms, with the combined VNB–tobramycin treatment
leading to an increased killing efﬁciency of approx. 20 and 25
times, respectively (Fig. 5b, c). Treatment with AuNP or pulsed
laser irradiation alone did not have a signiﬁcant effect on the
amount of CFUs in any of the bioﬁlms (p > 0.05). Neither did the
combination of AuNP with tobramycin, or laser treatment with
tobramycin, produce any additional effect compared to tobra-
mycin alone. Also VNB treatment by itself did not signiﬁcantly
decrease the number of CFUs. Taken together, these results
conﬁrm our hypothesis that the mechanical disruptive effect of
laser-induced VNB allows to substantially enhance drug penetra-
tion in bioﬁlms, leading to increased killing by at least 1 order of
magnitude under the condition of a single laser pulse per location
in the bioﬁlm.
It should be noted that the observed effects are not due to
heating of the bioﬁlms by the laser-irradiated AuNP as all the
thermal energy of the AuNP is converted to mechanical energy of
the expanding VNB33. This was conﬁrmed by temperature
measurements during laser treatment, showing no change in
temperature within the sample wells (Supplementary Figure 4).
The effect of repeated VNB formation. It is a common obser-
vation that AuNP tend to become fragmented upon laser irra-
diation, so that VNB typically can be formed only once34–36.
Surprisingly, however, this turned out to be different in bioﬁlms
where we noted that VNB could indeed be repeatedly formed
upon application of multiple laser pulses. This is illustrated in
Supplementary Movies 4 and 5 showing gradual dispersal of cell
clusters as VNB are repeatedly formed. While the exact reason for
this is unclear, we subsequently evaluated whether forming VNB
multiple times could enhance the effect of tobramycin further.
The effect of 10× exposure to VNB was evaluated on P. aerugi-
nosa and S. aureus bioﬁlms (Fig. 6). Tobramycin combined with
10× VNB-treatment, resulted in a more than >3000-fold
increased killing in P. aeruginosa bioﬁlms when compared to
tobramycin alone. This is in contrast to S. aureus bioﬁlms, where
repeated VNB formation only resulted in approx. 23 times more
killing than tobramycin alone. It shows that further cluster dis-
persal by repeated VNB formation can enhance tobramycin’s
efﬁciency further, but that the extent of this is species dependent.
VNB-treatment enhances transport in bioﬁlms. In order to
investigate our hypothesis that VNB can enhance antibiotic
transport through bioﬁlms, the bioﬁlm penetration of FITC-
dextrane was compared before and after VNB-formation by
confocal microscopy. As displayed in Fig. 7, after irradiating the
bioﬁlm with 1 laser pulse, the ﬂuorescence of FITC-dextrane
increased towards the center of the bacterial clusters, conﬁrming
the hypothesis that VNB-mediated cluster disruption results in
increased penetration of molecules into the clusters (see also
Supplementary Movies 6-11). It was also observed that repeated
VNB treatment could further increase the amount of ﬂuorescence
of FITC-dextrane that penetrated in the bacterial clusters.
The penetration of FITC-dextrane into the clusters was
quantiﬁed off-line using ImageJ (National Institutes of Health).
As displayed in Supplementary Figure 5, FITC-dextrane penetra-
tion efﬁciency was determined by comparing FITC-dextrane
ﬂuorescence intensity inside versus around the bacterial clusters
(after adjusting for the autoﬂuorescence). Image analysis revealed
that a single laser pulse increased FITC-dextrane penetration
efﬁciency from 0.48 to 0.81 (and could be increased to 0.84 after 3
laser irradiations). In conclusion, the creation of VNBs inside
bioﬁlms can locally disrupt the dense bioﬁlm clusters and cause
an increased penetration of molecules into the clusters.
Bacterial dispersal during VNB-treatment. As VNB treatment
disturbs the integrity of cell clusters, it is of interest to know to
which extent bacteria actually become released into the
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Fig. 3 AuNP penetration through bioﬁlms. Confocal images of AuNP
(magenta) in bioﬁlms of B. multivorans, P. aeruginosa, and S. aureus (green).
Left: Large-view 3-D confocal images showing various cell clusters. Width
= 212 µm, height= 212 µm, depth= 35 µm (B. multivorans, P. aeruginosa),
30 µm (S. aureus). Right: Magniﬁed view of the middle plane of selected cell
clusters showing the presence of AuNP (some examples are indicated with
white arrowheads) throughout the clusters. Scale bar= 50 µm
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supernatant. This is important as dispersed bacteria can dis-
seminate within the host leading to a possible spread of the
infection or even septic shock15. Furthermore, it has been
reported that dispersed cells possess a unique physiology, differ-
ent from their planktonic and bioﬁlm counterparts, in which they
are highly virulent (e.g., against immune system)37. To test this,
the number of colony forming units in the supernatants and
bioﬁlms of both P. aeruginosa and S. aureus was determined after
1× and 10× VNB treatment via plate counting. No signiﬁcant
differences were found between the numbers of CFUs in the
supernatant with or without VNB treatment (Fig. 8). This shows
that VNB treatment causes localized disturbance of the bioﬁlm
cell clusters, without spreading of bacteria into the environment.
In vivo toxicity assessment in Caenorhabditis elegans. Given the
positive results of VNB treatment, and with an eye on potential
in vivo application to bioﬁlm-related infections, we ﬁnally tested
the toxicity of AuNP at the concentration used here in an in vivo
C. elegans model. Both pristine AuNP as well as laser-irradiated
AuNP were evaluated. A synchronized population of L4 stage C.
elegans nematodes was fed with either AuNP (ﬁnal concentration
of 1.4E+ 10 AuNPmL−1) or OGM medium and incubated for
3 days. The amount of living/dead nematodes was determined by
light microscopy every 24 h. No signiﬁcant differences were found
in survival after 24, 48, and 72 h in C. elegans relative to the
control (Fig. 9). It gives the ﬁrst indication that the (laser-irra-
diated) AuNP do not cause acute toxic effects in the concentra-
tion used in the present study.
Discussion
CLSM images revealed that cationic 70 nm AuNP could efﬁ-
ciently penetrate deep into the dense cell clusters of B. multi-
vorans, P. aeruginosa, and S. aureus bioﬁlms. Many studies state
that bioﬁlms impede NP penetration because of their multi-
component matrix and the presence of dense cell clusters38,39.
However, at the same time, efﬁcient penetration of NP through
bioﬁlms has also been reported40. Indeed, NP diffusion through
bioﬁlms is highly dependent on physicochemical characteristics
such as NP surface charge and size41. For example, Duncan et al.
reported that cationic charges of amine-functionalized silica
present on the outer layer of nanocapsules, enabled them to
penetrate Escherichia coli bioﬁlms and deliver their therapeutic
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Fig. 4 Vapour nanobubble mediated bioﬁlm disruption. Dark ﬁeld microscopy images taken before, during, and about 2 s after a single nanosecond laser
pulse of 561 nm laser at a ﬂuence of 1.69 J cm−2. The yellow circle indicates the location where the laser pulse is delivered. Some visible VNB are indicated
with red arrowheads. CTRL: bioﬁlm cluster without AuNP. Scale bar= 100 µm
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antimicrobial payload42. Li et al. showed that surface charge
dictated the location of differently charged quantum dots inside
bioﬁlms, with cationic QDs being completely dispersed
throughout the bioﬁlm, whereas negatively QDs were bound at
the outer bioﬁlm layers43. Giri et al. found that high penetration
through S. aureus and P. aeruginosa bioﬁlms could be obtained
by decorating the AuNP surface with positive ligands44. Peulen
and Wilkinson examined the importance of NP size on bioﬁlm
penetration and found that bioﬁlm mobility is diminished in
function of increasing NP radius41. In addition, Forier et al. were
able to determine the NP size cut-off for optimal penetration into
dense bioﬁlm clusters of B. multivorans and P. aeruginosa, and
concluded that PEGylated NPs up to 0.1–0.2 µm are able to
penetrate these bioﬁlms to the same extent as small molecules45.
Generally these ﬁndings are in agreement with the present study,
where efﬁcient penetration of positively charged AuNP of 70 nm
was observed in all three bioﬁlms. Yet it remains of fundamental
interest to evaluate in future work the bioﬁlm penetration
potential of AuNP with different sizes and surface functionali-
zations, including PEGylated ones, to see which particle proper-
ties are best for VNB-mediated cluster disruption46.
By incubating the bioﬁlms with AuNP and applying sub-
sequent pulsed laser irradiation, it was possible to create VNB
inside all three studied bioﬁlms. VNBs are generated by illumi-
nating AuNP in biological tissues with pulsed laser light, leading
to evaporation of the surrounding water into VNB28. Considering
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the high water content of bioﬁlms and the fact that bioﬁlms can
be loaded with the aforementioned AuNP, VNB could be suc-
cessfully formed.
Applying 1× VNB treatment already interfered noticeably with
the bioﬁlm structure. This is due to the mechanical impact of the
laser-generated VNB which rapidly expand and implode, causing
high-pressure shock waves28. As shown in Fig. 4, besides the
formation of different nanobubbles, also micron-sized bubbles
were observed, which may be responsible for the more extensive
disruption of cell clusters (compared to the more localized dis-
organization induced by VNB). Formation of the bigger sized
bubbles is likely caused by aggregated AuNP (bioﬁlm-induced
AuNP aggregation), while the nanobubbles originated from
individual AuNP. Efﬁcient penetration of AuNP towards the
center of bioﬁlm clusters is believed to be a keystone of the
treatment’s success, because in this way the VNBs are created
inside the clusters, enabling a disruption force from within—
instead of only disrupting the bioﬁlm from the outer edges. It is
important to note that this technique is different from the more
traditional photothermal killing of bacteria, where the combined
use of AuNP and laser irradiation kills bacteria by producing
heat31,47,48. Despite numerous in vitro studies reporting the
effective eradication of bioﬁlms by photothermal treatment49–54,
translation into clinical practice may be difﬁcult because of heat
diffusion into the surrounding healthy tissue31,51. One study
reported on the destruction of Bacillus subtilis bioﬁlms grown on
a gold-coated substrate following pulsed laser irradiation. Laser
irradiation induced localized melting of the gold layer, resulting
in the formation of a fast liquid jet and fragmentation of the gold
layer49. While this affected the bioﬁlm structure, such an
approach is limited to applications where bioﬁlms are formed on
gold-coated surfaces. The approach presented here, however, is
more versatile in the sense that AuNP can be added to any bio-
ﬁlm irrespective of the surface on which it is formed and even to
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non-surface attached bioﬁlm aggregates. As such it could be
applied to e.g., bioﬁlm infections of wounds or dental root canals.
A particular advantage of VNB to sensitize bioﬁlms is that no
heat transfer into the surrounding tissue occurs because the heat
is efﬁciently converted into mechanical energy of the expanding
VNB30. In addition, due to the ﬁne control of laser light and
localized action of VNB, this concept allows very precise localized
treatment thus minimizing potential harm to the surrounding
healthy tissue. One might even consider the use of bacteria-
targeted Au to enhance the speciﬁcity even further31,47,50.
Other techniques such as shock waves and ultrasound have
also been investigated to render bioﬁlms more sensitive to anti-
biotics. In the study of Gnanadhas et al., the use of shock waves
increased P. aeruginosa and S. aureus bioﬁlm sensitivity to
ciproﬂoxacin by 100 to >1000 times24. In the study of Kopel et al.,
the combination of surface acoustic waves and gentamicin could
reduce the number of CFU of 48 h-old P. aeruginosa bioﬁlms by
2 log compared to the effect of gentamicin alone27. Some suc-
cesses have been achieved using low frequency ultrasound as well,
as summarized in a recent review55. However, tissue damage and
bleeding associated with the use of these approaches are of par-
ticular concern and because of this, treatments that are effective
in vitro can currently not be applied in vivo24,26,27. Clearly, much
work still needs to be done to further validate our new concept of
VNB-mediated bioﬁlm disruption as well, including performing
in vivo studies. Considering the inherent limited penetration of
light into tissue, the most likely applications are the treatment of
topical infections, such as the treatment of wound infections. In
this application, the AuNP will likely be applied to the wounds as
a topical suspension. After some incubation time, this can be
followed by a gentle rinsing step with a washing solution such as
physiological saline to remove excess unbound AuNP. In the next
step, the infected area will be irradiated with pulsed laser light to
generate VNB. Due to the unsurpassed ﬁne control of laser light,
we expect that unwanted side effects like tissue damage can be
reduced to a minimum. The use of light comes at its expense as
well, which is that light penetration into tissues is fairly limited
especially in the visible range. Although we used green-yellow
light in this study (561 nm), it is important to note that this is not
inherent to VNB generation, but only depends on the sensitizing
particle being used. For instance, by switching e.g., to gold
nanorods, the absorbance spectrum shifts to NIR wavelengths,
allowing deeper penetration into tissues. While treatment of
wounds with pulsed laser light is currently not performed to our
knowledge, it is of note that pulsed lasers that are used for tattoo
removal or port-wine stain treatment56,57 have the right char-
acteristics for VNB generation, so that at least from a technology
point the procedure should be clinically feasible. In the last step,
the required antimicrobial agent will be administered to the
VNB-treated wounds in the same way as is normally done in
wound care. It is of note that for the treatment’s success, it will be
crucial that the entire infected region is treated with AuNP and
tobramycin and irradiated by pulsed laser light in order to reduce
the infection. By scanning the laser beam in a (somewhat over-
lapping) raster pattern, a complete coverage of the infected area
can be assured. In addition, one could scan the wound multiple
times (as it was observed that repeated VNB-formations inside
bioﬁlms is possible) in order to minimize the chance that some
small parts would be missed, e.g., due to slight movement by the
patient during the scanning procedure. Another potential appli-
cation is the treatment of dental root canal infections, for which
bioﬁlm removal by laser-induced cavitation of the rinsing ﬂuid is
already being applied in the clinic58. Still, complete bioﬁlm
removal remains challenging and often incomplete due to the fact
that ﬂuid cavitation only affects the bioﬁlm from the outside.
Instead, if combined with AuNP to induce VNB from within the
bioﬁlms, it is expected that bioﬁlm removal would become more
effective. The AuNP can be dispersed in the disinfectant solution
that is normally used during the laser procedure so that no extra
steps will be needed. This should lead to more efﬁcient eradica-
tion of remaining bioﬁlm cells not only because of VNB shock-
waves, but also due to a better penetration of the disinfectants
that are present during the procedure.
For all types of bioﬁlms studied, the combined use of VNB and
tobramycin has a greater effect than tobramycin alone. Indeed,
the use of VNB signiﬁcantly increased the effect of tobramycin by
~80, ~20, and ~25 times in case of B. multivorans, P. aeruginosa,
and S. aureus bioﬁlms, respectively. This is in line with our
hypothesis that VNB treatment increases the drug ﬂux towards
deeper cell layers by creating more space between the cells.
Indeed, it was observed that VNB cause an inﬂux of molecules
into the clusters after laser irradiation. Repeated VNB treatment
resulted in an even bigger ﬂux of molecules towards the center of
the clusters. In addition, it may be that increased diffusion of
oxygen contributed to tobramycin’s improved efﬁciency as well.
Indeed, it has been shown that bioﬁlms also impede oxygen
diffusion, leading to different oxygenation levels throughout the
bioﬁlm, which play a part in the bioﬁlm tolerance towards anti-
microbials such as tobramycin6. Besides increasing net mass
transport, disruption of bioﬁlms could also have an impact on
other tolerance mechanisms that are derived from their complex
three-dimensional structure8. In future work, the effect of VNB-
disruption on persisters will be studied. This dormant, multidrug-
tolerant subpopulation of bioﬁlm cells have been proposed as an
important factor in bioﬁlm resilience59. It would be interesting to
see whether the increased transport of antibiotics by VNB-
mediated disruption of bioﬁlms would affect the number of
persisters present in the bioﬁlm population and their ability to
sustain antibiotic killing. In order to better understand the
underlying mechanisms of VNB-mediated bioﬁlm disruption,
future work will also assess the viscoelastic change of bioﬁlms
after VNB-treatment. Here, macroscopic rheology measurements
could be combined with Single Particle Tracking microrheology
experiments to come to an in-depth understanding of the visco-
elastic changes by laser-induced VNB60,61.
It is to be noted that we chose in this study to administer
tobramycin after laser treatment to avoid any detrimental effect of
the laser light on tobramycin. Clearly, in future work, it is of interest
to evaluate if the treatment’s efﬁciency could be further enhanced if
the antimicrobial agent is present during VNB-formation, thereby
having immediate access to the ruptured cell clusters.
100
C
. e
le
ga
ns
 
su
rv
iva
l (%
)
80
60
40
20
0
0 24 48
Hours
72
CTRL
AuNP
AuNP + laser
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During the experiments we rather surprisingly found that VNB
could be formed multiple times in bioﬁlms upon repeated laser
irradiation from the same batch of AuNP. This was unexpected as
we and others have found that nanosecond laser pulses induce
fragmentation of AuNP62, likely due to melting of AuNP and
subsequent surface evaporation into smaller sized fragments63.
The net result is that VNB can typically be formed only once
from AuNP. The reason why VNB can be formed multiple times
in bioﬁlms remains unclear at this point, but it may be that
fragments are still formed but held closely together due to the
matrix components. Indeed, it has been previously shown that
agglomerates of smaller AuNP can form VNB similar to a single
larger AuNP64. In addition, it may be that new AuNP become
available to laser irradiation as the clusters gradually disperse
upon application of multiple laser pulses. Whatever the under-
lying reason, by forming VNB multiple times, the cluster integrity
could be further compromised. In combination with 10× VNB
formation, tobramycin efﬁciency could be enhanced >3000 fold in
P. aeruginosa bioﬁlms. In case of S. aureus bioﬁlms, however,
repeated VNB treatment did not further increase the efﬁciency of
tobramycin compared to 1× VNB treatment. It may point to the
fact that for S. aureus bioﬁlms, probably other mechanisms,
besides hindered bioﬁlm diffusion, contribute to bioﬁlm resis-
tance, such as enzymatic alteration of tobramycin65. If this turns
out to be the case, the use of nanocarriers, such as liposomes, that
shield the encapsulated antibiotic from degradation and/or
interactions with the bioﬁlm matrix could be a potentially useful
strategy.
Although substantial cluster disruption was noticed when
bioﬁlms were treated with 10× VNB, no dispersal of bacteria in
the supernatant occurred. The aim of classic dispersal agents,
such as DNase I, is to disturb tight bioﬁlm architectures and
induce concomitant release of bacteria, in order to increase their
sensitivity towards antibiotics. Nonetheless, one major drawback
of these methods is the possible re-colonization of the dispersed
bacteria, which could lead to life-threatening sepsis or bioﬁlm
formation in other locations of the human body15,23. VNB
treatment is highly controlled and causes only local bioﬁlm
deformation, without spreading of bacteria in the environment,
and hence poses less risk of spreading the infection and causing
disease exacerbation.
Our data showed that adding AuNP alone did not cause a
signiﬁcant decrease of cell viability in any of the studied bioﬁlms.
While it points to the biocompatible nature of AuNP, we addi-
tionally assessed AuNP toxicity in an in vivo C. elegans model.
The good correlation of the invertebrates endpoints to rat
LD50s66 and their highly conserved toxicity pathways with
humans67, make them an excellent model for in vivo whole
organism toxicity testing68–70. Furthermore, it has been shown
that C. elegans is a well-suited platform to study the in vivo toxic
effects of various types of AuNP71,72. We showed that no sig-
niﬁcant differences were found in the nematode survival between
control and AuNP treated groups, highlighting the non-toxic
nature of this approach. Also laser-irradiated AuNP, which are
fragmented into smaller pieces, did not cause any noticeable
toxicity. Spurred by these positive results, future research should
also assess the AuNP toxicity in humans in clinical trials,
depending on the intended application, in order to cover human-
speciﬁc toxicological pathways. Currently, different Au-based
particles have entered clinical trials, such as Phase-II Aurimmune
(CytImmune®) and Aurolase (Nanospectra Biosciences®) for the
treatment of solid tumors and silica-gold nanoparticles for the
treatment of plaques73–75.
In conclusion, increasing antibiotic penetration through bio-
ﬁlms via laser-irradiated AuNP is a very promising route to
combat the problem of bioﬁlm-related infections. Depending on
the type of bioﬁlm and the conditions used, the effect of tobra-
mycin could be enhanced over 3 orders of magnitude. To fully
unravel the potential of this new concept, it will be of interest in
future research to explore its potential for relevant in vivo
applications that are compatible with laser treatment, such as
wound- and root canal-related bioﬁlms infections. Furthermore,
because we have shown that VNB-treatment is a robust technique
which can render both Gram-negative and Gram-positive bio-
ﬁlms more sensitive to tobramycin, it is of interest to test the
concept in multispecies bioﬁlms.
Methods
Materials and strains. B. multivorans LMG18825 and P. aeruginosa LESB58
(LMG 27622) were obtained from the BCCM/LMG bacteria collection (Ghent
University, Belgium), while S. aureus Mu50 was obtained from ATCC (Manassas,
VA). Mueller Hinton Agar/Broth, Lysogeny Agar/Broth and pure Agar were
purchased from Lab M Limited (Lancashire, UK). Simulated wound ﬂuid (1:1 fetal
bovine serum: 0.9% NaCl (w/v) in 0.1% Peptone) was prepared in-house. Fetal
bovine serum was purchased from HyClone™ (Pierce, Rockford, IL, USA), NaCl
was obtained from Applichem (Darmstadt, Germany) and Peptone was derived
from BD Diagnostics (New Jersey, USA). Nematode Growth Medium (NGM) agar
plates (3 mgmL−1 NaCl, 17 mgmL−1 Agar, 2.5 mg mL−1 Bacto Peptone, 5 mg mL
−1 cholesterol, 134 mgmL−1 KPO4 buffer pH 6, 120 mgmL−1 MgSO4, 110 mgmL
−1 CaCl2) and M9 buffer (3 g L−1 KH2PO4, 6 g L−1 Na2HPO4, 0.5 g L−1 NaCl, 1 g L
−1 NH4Cl) were prepared in-house. Cholesterol, potassium phosphate buffer pH 6
(108.3 g L−1 KH2PO4, 35.6 g L−1 K2HPO4), MgSO4, CaCl2, KH2PO4, Na2HPO4
were purchased from Sigma-Aldrich (Saint Louis, MO, USA). NH4Cl was obtained
from Fisher Scientiﬁc (Loughborough, Leics, UK). AuNP (Nanopartz, USA) were
diluted 1:60 in ultrapure water prior to use. According to the manufacturer’s
information, AuNP were conjugated with a myriad of different covalent SH-
branched and straight amine polymers with different MW from 5 to 40 kDa, all
manufactured by Nanopartz. As puriﬁcation, a multistep dialysis was performed
resulting in less than 0.01% w-w reactants. SYTO59 was obtained from Thermo-
Fisher Scientiﬁc (Eugene, USA).
Bioﬁlm formation. Bioﬁlms were grown aerobically in 96-well SensoPlatesTM
(Greiner Bio-One, USA) with microscopy grade borosilicate glass bottom for 24 h
at 37 °C. Brieﬂy, bioﬁlms of B. multivorans, P. aeruginosa, or S. aureus were grown
in Mueller Hinton Broth, Lysogeny Broth, or simulated wound ﬂuid, respectively.
The wells of the 96-well SensoPlate were ﬁlled with 100 µL of the bacterial sus-
pension, and incubated at 37 °C. After 4 h, the adhered cells were washed with
physiological saline (0.9% NaCl (w/v)), covered with medium and incubated for
another 20 h at 37 °C.
Evaluation of the bioﬁlm structure by CLSM. To conﬁrm the presence of a
bioﬁlm, laser scanning confocal microscopy was used. Bacteria were stained with
the red ﬂuorescent nucleic acid stain SYTO59 according to the manufacturer’s
instructions. 100 µL of a 20 µM SYTO 59 solution was added to the bioﬁlms and
incubated at room temperature for 15 min. Free ﬂuorophores were then removed
by washing the bioﬁlm with 100 µL physiological saline. CLSM was performed with
a Nikon C1si confocal laser scanning microscope equipped with a Plan Apoc-
hromat 60 × 1.4 NA oil immersion objective lens (Nikon). The pictures were
captured with NIS Elements Advanced Research package. SYTO59 was excited
with a 636 nm diode laser (CVI Melles Griot, Albuquerque, NM, USA).
AuNP penetration through bioﬁlms. The average hydrodynamic size and zeta
potential of the AuNP were measured with DLS. After diluting the particles 1:100
in ultrapure water, 1 mL of the sample was transferred in a folded capillary cell and
measured with the Zetasizer Nano-ZS (Malvern, Worcestershire, UK) in triplicate.
The morphological structure of the AuNP was visualized with JEM 1400plus
Transmission Electron Microscopy (TEM) (JEOL, Tokyo, Japan) operating at 60
kV. A 50 µL drop of a 1:10,000 dilution of the Au NP was blotted on formvar/C-
coated hexagonal copper grids (EMS G200H-Cu) for 20 min and washed 5 times in
ddH2O. The extinction spectrum of the AuNP was recorded with a UV–VIS
spectrophotometer (Nanodrop 2000, ThermoScientiﬁc, Wilmington, DE, USA).
After 24 h of growth, the supernatant was removed and 100 µL of an aqueous
dispersion of AuNP (1.4E+ 10 AuNPmL−1) was added to the bioﬁlm. To allow
complete penetration, the bioﬁlms were incubated for 15 min at room temperature.
Next, the supernatant was removed and the bioﬁlms were washed with 100 µL
physiological saline in order to remove the excess AuNP.
To evaluate whether the AuNP were able to penetrate the bioﬁlms, the location
of AuNP inside the bioﬁlms was investigated by CLSM. To visualize the bioﬁlms,
the bacteria were stained with SYTO59, as mentioned before and excited at 636 nm.
AuNP were simultaneously visualized in reﬂection mode using the 561 nm laser
line (CVI Melles Griot, Albuquerque, NM, USA).
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Formation and visualization of VNB inside bioﬁlms. A home-made optical set-
up was used to generate and detect VNBs inside the bioﬁlms, according to the
optical design shown in Supplementary Figure 230. The set-up is built around an
inverted TE2000 epi-ﬂuorescence microscope (Nikon, Nikon BeLux, Brussels,
Belgium) equipped with a Plan Fluor 10× 0.3 NA objective lens (Nikon). An
Optical Parametric Oscillator (OPO) laser (OpoletteTM HE 355 LD, OPOTEK Inc.,
Faraday Ave, CA, USA) produces laser pulses of 7 ns tuned to 561 nm in order to
excite the localized surface plasmon resonance of the AuNP while at the same time
being compatible with optical ﬁlters in the set-up. The energy of each laser pulse is
monitored with an energy meter (J-25MB-HE&LE, Energy Max-USB/RS sensors,
Coherent) synchronized with the pulsed laser. In this study, a laser pulse ﬂuence of
1.69 J cm−2 was used. An automatic Prior Proscan III stage (Prior scientiﬁc Ltd.,
Cambridge, UK) is used to scan the sample through the 150 µm diameter laser
beam (ﬁring at 20 Hz) line by line with a scanning speed of 3 mm s−1 and an
interline distance of 0.15 mm (spatial overlap between subsequent laser pulses
ensures that each location of the bioﬁlm receives at least 1 laser pulse).
As VNBs efﬁciently scatter light, the generation of VNB inside bioﬁlms could be
detected by dark-ﬁeld microscopy. Because of the short nature of VNB generation
(lifetime < 1 µs), the camera (EMCCD camera, Cascade II: 512, Photometrics,
Tucson, USA) was synchronized with the pulsed laser by an electronic pulse
generator (BNC575, Berkeley Nucleonics Corporation, CA, USA). Dark ﬁeld
pictures were taken before illumination, during VNB formation and immediately
after illumination, in order to elucidate conformational changes in the bioﬁlm
structure due to VNB formation. For dark ﬁeld imaging, the bioﬁlms were cultured
24 h at 37 °C in 50 mm glass bottom dishes (No. 1.5 coverslip) (MatTek
Corporation, Ashland, USA).
Combining VNB-induced cluster disruption and antibiotics. The combined
effect of VNB-mediated disturbance of the bioﬁlm and antibiotic treatment was
evaluated for 3 different organisms. The laser treatment described above was
applied 1× or 10× as discussed in the text. After laser treatment, as described
before, 100 µL supernatant was removed and the bioﬁlms were treated with 100 µL
tobramycin or control solution (0.9% NaCl (w/v)). In order to avoid photo-induced
inactivation of the antibiotic, tobramycin was added after laser treatment. Tobra-
mycin was dissolved in physiologic saline and sterilized by membrane ﬁltration
through a 0.22 µm ﬁlter. Tobramycin concentrations of 32, 16, and 1024 µg mL−1
were used to treat B. multivorans, P. aeruginosa, and S. aureus bioﬁlms, respec-
tively. After treatment of 24 h at 37 °C, the sessile cells were washed with phy-
siologic saline and harvested by 2 rounds of 5 min vortexing (900 rpm, Titramax
1000, Heidolph Instruments, Schwabach, Germany) and 5 min sonication (Branson
3510, Branson Ultrasonics Corp., Danbury, CT, USA). Next, the number of CFU/
bioﬁlm per condition was determined by plating (n= 6 × 3).
VNB-treatment enhances transport in bioﬁlms. In order to investigate our
hypothesis that VNB can enhance antibiotic transport through bioﬁlms, an in-
depth microscopic analysis was performed of the penetration of a model ﬂuor-
escent molecule into P. aeruginosa bioﬁlms before and after VNB-treatment.
Therefore, we compared the bioﬁlm penetration of a model ﬂuorophore (4 kDa
FITC-dextrane) before and after VNB-formation by confocal microscopy. After
cultivation of 24 h-old P. aeruginosa bioﬁlms, 70 nm AuNP were added to the
bioﬁlms and the bacterial clusters were stained with 20 µM SYTO59. After a
washing step with physiological saline, FITC-dextrane 4000 (Sigma) at a con-
centration of 4 mgmL−1 was added to the bioﬁlms. Bioﬁlms were visualized in 3D
by confocal microscopy. SYTO59 was excited with a 636 nm diode laser, while
FITC-dextrane was excited using a 488 nm laser. In total, 20 different bacterial cell
clusters were imaged in dual color (n= 5 × 4). After laser treatment of the clusters,
images were recorded at the exact same locations, by making use of reference
points in the 96-well plate (diamond scratches).
The penetration of FITC-dextrane into the clusters was quantiﬁed off-line using
ImageJ (National Institutes of Health). The image analysis protocol is displayed in
Supplementary Figure 5. First, the image containing the signal of the bacteria was
analyzed in order to deﬁne the bacterial cell clusters as regions of interest (ROI).
After intensity thresholding, a binary image was created in which each pixel was
designated as being either inside or outside the bacterial cluster. Only ROI with a
surface area larger than 2 µm2 were retained for analysis (avoiding inclusion of
single bacterial cells). Finally, this set of ROIs were applied to the image containing
the ﬂuorescence of FITC-dextrane and the average ﬂuorescence intensity of pixels
within each ROI (Iin) was measured, as well as the ﬂuorescence around the clusters
(Iout). Autoﬂuorescence was determined by recording images of SYTO59 stained
bioﬁlms without FITC-dextrane using the same image settings (performed in
triplicate to determine the average value Ibg;in and Ibg;out). Finally, FITC-dextrane
penetration efﬁciency was calculated according to:
Iin  Ibg;in
Iout  Ibg;out
ð1Þ
Temperature assessment during VNB-treatment. To conﬁrm that the observed
effects in bacterial killing are not caused by mere heat generation, the sample
temperature was monitored during laser illumination. A remote temperature
sensor (Delta T Reference Thermistor, CHROMAPHOR, Germany) was inserted
in the bioﬁlm well to record the temperature during laser illumination (120 s for 1
well of a 96-well plate). Correct functioning of the temperature sensor was checked
with ultrapure water of 4 and 50 °C.
Bacterial dispersal during VNB-treatment. Bacterial dispersal by VNB treatment
was assessed by determining the number of colony forming units in the super-
natants and bioﬁlms of both P. aeruginosa and S. aureus via plate counting (n=
3 × 3).
In vivo toxicity assessment in Caenorhabditis elegans. To investigate the
translational potential of VNB treatment, AuNP toxicity was evaluated in an
in vivo toxicity test with Caenorhabditis elegans N2 (glp-4; sek-1). Both pristine and
irradiated AuNP were included in the toxicity assay. In brief, C. elegans was
maintained on NGM agar plates, which were seeded with Escherichia coli OP50.
The plates were incubated for 6 h at 37 °C to allow the E. coli lawn to grow. Next, C.
elegans worms were transferred from one NGM plate to another by the chunking
technique. The chunked C. elegans plates were incubated for 2 weeks at 12 °C in
order to cultivate the nematodes. Then, an egg-prep/bleaching step was performed
in order to obtain a synchronized C. elegans population. Therefore, the nematodes
were washed 2 times with physiological saline followed by a hypochlorite bleaching
step. The obtained eggs were transferred to E. coli seeded NGM plates and incu-
bated for 3 days at 25 °C. The synchronized nematodes (L4 stage) were then
collected in OGM medium containing 95% M9 buffer, 5% Brain Heart Infusion
Broth (Oxoid), and 10 µgmL−1 cholesterol (Sigma-Aldrich). The nematode sus-
pension was standardized, so that each well of a 96-well ﬂat-bottomed microtiter
plate contained 25 nematodes. C. elegans was fed with 25 µL of AuNP suspension
(ﬁnal concentration of 1.4E+ 10 AuNPmL−1) for toxicity testing, whereas the
controls were treated with OGM medium. The plates were incubated for 3 days at
25 °C and the number of living/dead nematodes were determined every 24 h by
using an EVOS FL Auto Microscope (Life Technologies, USA) at 2× magniﬁcation
(n= 4 × 6).
Statistical data analysis. SPSS Statistics 24 (SPSS, Chicago, IL, USA) was used to
analyze the data. The Shapiro–Wilk test was used to test the normality of the data
sets. The one-way analysis of variance test and independent samples T-test were
used for normal distributed data. The Kruskal–Wallis test and Mann–Whitney U
test were used for non-normally distributed data. Differences with a p-value < 0.05
were considered signiﬁcant.
Data availability
The data that support the ﬁndings of the study are available in this article and its
Supplementary Information ﬁles, or from the corresponding author upon request.
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